HQY HealthEquity Corp Forward Price-to-Revenue Multiple
HealthEquity, Inc. (HQY) is digitizing health savings account management via cloud-based AI, a trend reflected in the upward trajectory of the expected P/S metric. US insurance law and asset growth guarantee business stability. Leadership in the HSA niche ensures high margins and pricing power. The value of 3.30 indicates the current valuation of the company relative to its projected sales.
HQY (HealthEquity Building): analytical breakdowns and indicator data
- market price and analyst price targets:
- market capitalization data:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio HealthEquity, Inc.|HQY - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio HealthEquity, Inc.|HQY - Aggregate Debt Obligations|Debts to Book Capitalization HealthEquity Building|HQY - Long-Term Debt Volume|Company Short-Term Debt HealthEquity|Quick Ratio healthequity.com
- financial results and valuation multiples details:
HQY - Net Income|Future Profit HealthEquity, Inc.|HQY - Business Payback Period|Forward P/E Multiple HealthEquity Corp|HQY - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HealthEquity Building|HQY - Operating profit before depreciation charges|Net earnings per share for the last 12 months HealthEquity|HQY - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth healthequity.com|HQY - Expected net earnings per share growth this year|Expected earnings per share growth for next year HealthEquity, Inc.
- sales volume and revenue indicators:
Summary company analysis:HealthEquity HQY
Market expectations for HealthEquity, Inc. (HQY) depend on the company's ability to maintain its dominance in the HSA segment amid expansion by fintech behemoths. The expected P/S ratio compares current market capitalization with projected revenue, allowing investors to assess whether the premium for network effects and employer integration is justified to avoid overpaying for future business growth.
Analysis of competing companies
Price-to-Projected Revenue Ratio Veeva VEEV|Projected Price to Revenue Doximity Inc|WAY: Forward Price-to-Revenue Multiple|CRVL - Forward P/S Multiple|PRVA: Forward P/S Multiple|HURN - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CERT|OMCL (Omnicell Inc) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple GDRX (GoodRx Corp)|SDGR - Market Cap to Future Revenue Ratio|Phreesia, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales OMDA|Evolent Health - Forward P/S Multiple|Market Cap to Expected Sales Ratio HealthStream Inc HSTM|Definitive Healthcare Inc. (DH) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue CCSI|AGL (Agilon Health) - Forward P/S Multiple|Forward Price-to-Revenue Multiple absci.com (ABSI)|Forward Price-to-Revenue Multiple SY (So-Young International Inc.)|Market Cap to Expected Sales Ratio NRC Health|Forward P/S Multiple SPOK (Spok Corp)|Forward Price to Sales OPRX|TBRG - Price-to-Projected Revenue Ratio|Projected Price to Revenue simulations-plus.com (SLP)|SOPH (sophiagenetics.com) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio Health Catalyst Inc. (HCAT)|CCLD (CareCloud Inc.) - Forward P/S Multiple|Research Solutions Inc. (RSSS) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple DLHC (DLH Holdings Corp.)|Price to Expected Revenue Ratio ONMD|Scienture - Forward Price-to-Revenue Multiple|Forward Price to Sales HCTI|ISPC - Price-to-Projected Revenue Ratio|Bullfrog AI Holdings (BFRG) - Forward Price-to-Revenue Multiple|WORX: Forward P/S Multiple|Market Cap to Future Revenue Ratio msprecovery.com (MSPR)|ICCT (iCoreConnect, Inc.) - Forward P/S Multiple|Market Cap to Projected Revenue MEDS (TRxADE HEALTH Inc)|Forward P/S Multiple ORGS|RCM (r1rcm.com) - Forward Price to Sales|Forward P/S Multiple SHCR (Sharecare, Inc.)|streamlinehealth.net (STRM) - Market Cap to Future Revenue Ratio|Syra Health - Forward P/S Multiple|AMEH - Forward P/S Multiple|Model N Corp (MODN) - Price-to-Projected Revenue Ratio|NXGN (NextGen Healthcare Corp) - Price-to-Projected Revenue Ratio
